Patent Assignment
Reel/Frame 033686/0732
Lien
Recorded: 2014-09-04
Pages: 5
Assignor
NABRIVA THERAPEUTICS AG
Executed: 2014-07-16
Assignee
KREOS CAPITAL IV (UK) LIMITED
25-28 OLD BURLINGTON STREET, LONDON, W1S 2AN, UNITED KINGDOM
Covered Property
(1)
Pleuromutilin Derivatives for Use in the Treatment of Diseases Mediated by Microbes
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 11, 2013
From: RIEDL, ROSEMARIE; THIRRING, KLAUS; HEILMAYER, WERNER
To: NABRIVA THERAPEUTICS AG
Reel/Frame 029961/0298 →
Cancellation of Lien
Nov 23, 2015
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037152/0770 →
Intellectual Property Security Agreement
Dec 20, 2018
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 047973/0110 →
Release of Security Interest
Mar 3, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH; ZAVANTE THERAPEUTICS, INC.
Reel/Frame 062881/0090 →
Corrective Assignment to Correct the Receiving Party Data and the Assignment Document Previously Recorded at Reel: 062881 Frame: 0090. Assignor(S) Hereby Confirms the Release of Security Interest.
Jun 20, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 064312/0350 →
Nunc Pro Tunc Assignment
Apr 3, 2025
From: NABRIVA THERAPEUTICS GMBH
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 070725/0291 →